Regulatory briefing

Our regulatory briefings section delivers current and up-to-date legal and regulatory news relating to all aspects of the CBD industry. It covers individual regulation changes across the world, policy and governmental changes that impact the industry and technological and medical innovations that affect how the industry is regulated, to name a few.

BfR issues warning over adulterated German e-liquids

Written by CBD-Intel || 21st February 2020 || Regulatory briefing |

Germany's Federal Institute for Risk Assessment (BfR) recently issued a warning on e-liquids that it believed to be containing synthetic cannabinoids, after at least eight teenagers suffered medical complications from an as yet unconfirmed source ...